Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Single-Arm Study to Assess the Safety of Transplantation With Human Placental-Derived Stem-Cells Combined With Unrelated and Related Cord Blood in Subjects With Certain Malignant Hematologic Diseases and Non-Malignant Disorders

NCT01586455 is registered in ClinicalTrials.gov with New York Medical College as lead sponsor.

NCT NCT01586455
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01586455 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Single-Arm Study to Assess the Safety of Transplantation With Human Placental-Derived Stem-Cells Combined With Unrelated and Related Cord Blood in Subjects With Certain Malignant Hematologic Diseases and Non-Malignant Disorders
Lead sponsor
New York Medical College
Phase
Phase 1
Overall status
Completed
Start date
April 30, 2013
Completion date
September 30, 2022
Enrollment
43 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

acute lymphocytic leukemia, acute myelogenous leukemia, adrenoleukodystrophy, amegakaryocytic thrombocytopenia, batten disease, diamond-blackfan anemia, fucosidosis, gaucher's disease, krabbe's disease, metachromatic leukodystrophy, mucopolysaccharidosis i, mucopolysaccharidosis vi, myelodysplastic syndrome, niemann-pick disease, severe aplastic anemia, wolman disease